Hints and tips:
Related Special Reports
...Pharma groups were realising that “the best way to convert customers is through patient portals where they can act as a consumer in medicine”, added Mackey....
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
Company would have been better off following Roche’s route to market for anti-obesity treatment
...“I’d put Vertex in my pharma top three [to invest in].” This year, Vertex’s market capitalisation surpassed $100bn for the first time....
...Unlike their big pharma cousins, they were better known for operational and financial acumen than cutting edge science....
...That concept is controversial by itself as the Purdue Pharma opioid case, now in front of the Supreme Court, shows....
...US President Joe Biden has put his fight against Big Pharma at the centre of his re-election campaign, championing his efforts to lower drug prices through the Inflation Reduction Act....
...Lex this week opined on three separate pharma outliers praying for rescues from their “lab rats” — as medical researchers sometimes call themselves....
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...A shrinking domestic market is forcing Japan Inc to look for growth overseas. Ultra-low interest rates back home have further whetted the appetite for deals....
...Some pharma companies disputed the annual cost figures published by the health department....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Big Pharma has always bought out small drug developers to restock its pipelines. Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
US regulator sues to block takeover of biotech group Horizon Therapeutics
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
International Edition